Bausch & Lomb (BLCO) Capital Expenditures (2021 - 2026)
Bausch & Lomb (BLCO) posted Capital Expenditures of $100.0 million for Q1 2026, up 145.05% on a QoQ basis from -$222.0 million in Q4 2025, and up 92.31% year-over-year from $52.0 million in Q1 2025.
Bausch & Lomb (BLCO) Capital Expenditures (2021 - 2026) Analysis & Trends
Bausch & Lomb's Capital Expenditures history runs 6 years deep, the most recent figure standing at $100.0 million for Q1 2026.
- Quarterly Capital Expenditures rose 92.31% year-over-year to $100.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.0 million (up 141.46% YoY) and the FY2025 annual result came in at $51.0 million, down 8.93% from the prior year.
- Capital Expenditures was $100.0 million for Q1 2026 at Bausch & Lomb, up from -$222.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $230.0 million in Q3 2025 and bottomed at -$222.0 million in Q4 2025.
- A 5-year average of $33.1 million and a median of $22.0 million in 2023 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 11600.0% in 2025, while the deepest fall reached 2566.67% in 2025.
- Bausch & Lomb's Capital Expenditures stood at $157.0 million in 2022, then dropped by 6.37% to $147.0 million in 2023, then tumbled by 93.88% to $9.0 million in 2024, then tumbled by 2566.67% to -$222.0 million in 2025, then soared by 145.05% to $100.0 million in 2026.
- Business Quant data shows BLCO's Capital Expenditures at $100.0 million in Q1 2026, -$222.0 million in Q4 2025, and $230.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | 100.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | -222.00 Mn |
| Dec 31, 2025 | -222.00 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Jun 30, 2025 | -9.00 Mn |
| Jun 30, 2025 | -9.00 Mn |
| Mar 31, 2025 | 52.00 Mn |
| Mar 31, 2025 | 52.00 Mn |
| Dec 31, 2024 | 9.00 Mn |
| Dec 31, 2024 | 9.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | 67.00 Mn |
| Mar 31, 2024 | 67.00 Mn |
| Dec 31, 2023 | 147.00 Mn |
| Dec 31, 2023 | 147.00 Mn |